Clinical suspicion of family history usually leads to genetic testing to identify a pathologic variant in DNAJC19. Biochemical testing to identify markedly elevated levels of 3-methylglutaconic acid and 3-methylglutaric acid in blood, urine or cerebrospinal fluid can also be used to make the diagnosis.